MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Mild-Intensity Whole Body Hyperthermia (WBH) for Major Depressive Disorder

Phase 2

Suspended

Conditions: Major Depressive Disorder

Interventions: Drug: Tocilizumab
Drug: Placebo
Device: Whole-Body Hyperthermia

First Posted Date: 2018-12-26

Last Posted Date: 2024-03-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 35

Registration Number: NCT03787290

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Pilot Trial of Contingency Management for Long-Term Cannabis Abstinence

Not Applicable

Completed

Conditions: Cannabis Use
Adolescent Behavior

Interventions: Behavioral: Contingency Management

First Posted Date: 2018-12-24

Last Posted Date: 2024-08-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 6

Registration Number: NCT03786224

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Chemical Peels and Fractional Laser on IGF-1 Levels in Skin

Not Applicable

Conditions: Skin Cancer

Interventions: Device: Fractional Laser and Chemical Peel

First Posted Date: 2018-12-13

Last Posted Date: 2020-10-22

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT03775031

Locations: 🇺🇸
Massachusetts General Hospital Clinical Unit for Research Trials and Outcomes in Skin, Boston, Massachusetts, United States

A Virtual Reality Study of Cognitive Biases in Body Dysmorphic Disorder

Completed

Conditions: Body Dysmorphic Disorders
Healthy

Interventions: Other: Virtual reality experience

First Posted Date: 2018-12-12

Last Posted Date: 2019-09-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 58

Registration Number: NCT03773549

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

AZD6738 for Patients With Progressive MDS or CMML

Phase 1

Recruiting

Conditions: Leukemia
Myelodysplastic Syndrome

Interventions: Drug: AZD6738

First Posted Date: 2018-12-10

Last Posted Date: 2024-03-15

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 52

Registration Number: NCT03770429

Locations: 🇺🇸
BIDMC, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

and more 1 locations

A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors

Not Applicable

Active, not recruiting

Conditions: Cancer

Interventions: Other: 3RP-AYA
Other: Waitlist control

First Posted Date: 2018-12-07

Last Posted Date: 2025-06-04

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 72

Registration Number: NCT03768336

Locations: 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

Waitlist-Control Trial of Smartphone CBT for Major Depressive Disorder (MDD), Withdrawn

Not Applicable

Withdrawn

Conditions: Major Depressive Disorder

Interventions: Device: Smartphone-delivered CBT for MDD

First Posted Date: 2018-12-07

Last Posted Date: 2025-06-04

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT03769350

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Waitlist-Control Trial of Smartphone CBT for Obsessive-Compulsive Disorder (OCD)

Not Applicable

Withdrawn

Conditions: Obsessive-Compulsive Disorder

Interventions: Device: Smartphone-delivered CBT for OCD

First Posted Date: 2018-12-06

Last Posted Date: 2022-08-08

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT03767491

Locations: 🇺🇸
Anna Schwartzberg, Boston, Massachusetts, United States

Brain Mechanisms of Video-Guided Acupuncture Imagery Treatment on Chronic Low Back Pain

Not Applicable

Active, not recruiting

Conditions: Chronic Pain

Interventions: Other: Sham VGAIT (Video-Guided Acupuncture Imagery Treatment)
Other: Verum VGAIT (Video-Guided Acupuncture Imagery Treatment)

First Posted Date: 2018-12-05

Last Posted Date: 2025-05-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 80

Registration Number: NCT03765879

Locations: 🇺🇸
Massachusetts General Hospital, Charlestown, Massachusetts, United States

Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia

Phase 4

Withdrawn

Conditions: Bipolar Disorder
Insomnia

Interventions: Drug: Suvorexant (Belsomra)
Drug: Placebo

First Posted Date: 2018-12-05

Last Posted Date: 2021-02-21

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT03764683

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy